MBXBF (Microbix Biosystems) Interest Expense: $-0.71 Mil (TTM As of Mar. 2026)

What is Microbix Biosystems Interest Expense?

Microbix Biosystems MBXBF +6.14% 53 Interest Expense is $-0.71 Mil as of Mar. 2026. GuruFocus rates MBXBF with a GF Score™ of 53/100 and a GF Value™ of $0.18 (Modestly Overvalued). The stock has 8 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Microbix Biosystems's interest expense for the three months ended in Mar. 2026 was $ -0.19 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.71 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Microbix Biosystems's Operating Income for the three months ended in Mar. 2026 was $ -0.92 Mil. Microbix Biosystems's Interest Expense for the three months ended in Mar. 2026 was $ -0.19 Mil. Microbix Biosystems did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Microbix Biosystems (OTCPK:MBXBF) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Microbix Biosystems's Interest Expense for the three months ended in Mar. 2026 was $-0.19 Mil. Its Operating Income for the three months ended in Mar. 2026 was $-0.92 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was $4.27 Mil.

Microbix Biosystems's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Microbix Biosystems did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Microbix Biosystems Interest Expense Historical Data

* Premium members only.

The historical data trend for Microbix Biosystems's Interest Expense can be seen below:

Microbix Biosystems Interest Expense Chart

Microbix Biosystems Annual Data

Trend

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Sep25

Interest Expense

Get a 7-Day Free Trial

-1.27

-0.62

-0.68

-0.69

Microbix Biosystems Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Interest Expense	Get a 7-Day Free Trial															-0.18	-0.17	-0.18	-0.18	-0.19

53GF Score

Microbix Biosystems Inc MBXBF

Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Microbix Biosystems Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.71 Mil.

Frequently Asked Questions Learn more about Interest Expense →

What does a Interest Expense of $-0.71 Mil mean?

Microbix Biosystems (MBXBF) has a Interest Expense of $-0.71 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Microbix Biosystems and its competitors.

Is Microbix Biosystems' Interest Expense too high?

Microbix Biosystems' current Interest Expense is $-0.71 Mil. Overall, Microbix Biosystems has a GF Score™ of 53/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Microbix Biosystems' Interest Expense compare to VRTX and REGN?

Microbix Biosystems' Interest Expense of $-0.71 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Interest Expense for a Biotechnology company?

A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Interest Expense mean?

A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Microbix Biosystems and its competitors. Microbix Biosystems's current Interest Expense is $-0.71 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Microbix Biosystems stock overvalued right now?

Based on GuruFocus' analysis, Microbix Biosystems (MBXBF) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.18, compared to a current price of $0.22 — trading 19.9% above its estimated fair value. The current Interest Expense is $-0.71 Mil. Microbix Biosystems' overall GF Score™ is 53/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Interest Expense calculated?

Interest Expense is calculated from a company's financial statements. For Microbix Biosystems (MBXBF), the current Interest Expense is $-0.71 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Microbix Biosystems (MBXBF) Overvalued in 2026?

Based on GuruFocus' analysis, Microbix Biosystems stock appears to be overvalued. The current stock price of $0.22 is trading 19.9% above its estimated GF Value™ of $0.18. GuruFocus considers Microbix Biosystems to be Modestly Overvalued.

Key valuation signals for MBXBF:

Interest Expense: $-0.71 Mil
GF Value™: $0.18 vs. price of $0.22 (19.9% above fair value)
GF Score™: 53/100 with 8 warning signs

No single metric tells the full story. See the MBXBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Microbix Biosystems Business Description

Industry Healthcare Biotechnology

Comparable Companies XCNQ:DTC TSX:BCT NEOE:ONCO XCNQ:QNTM TSX:MDNA TSXV:ALZI TSXV:MIR TSXV:SHRX TSXV:NRX TSX:RVX VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges MBX:Canada

Address 265 Watline Avenue, Mississauga, ON, CAN, L4Z 1P3

Website https://www.microbix.com

Microbix Biosystems Inc develops biological products and technologies. There are two operating segments: The development, manufacturing, and sale of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows, and viral transport medium to enable collection of patient test samples; and the development and commercialization of novel and proprietary products or technologies such as Kinlytic. Geographically, it derives a majority of revenue from North America and also operates in Europe and other foreign countries.

53GF Score

Get the complete analysis for MBXBF

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.22

Price

$0.18

GF Value

View MBXBF Analysis

See Interest Expense data for all stocks →